All News

RWCS 2021 card

RWCS Highlights - Day 4

d Rachel Tate, DO

As another year at RWCS in Maui wrapped up, I’m so thankful I had the opportunity to participate remotely. Here are my day 4 #RWCS2021 pearls from the Novel Therapies Year in Review (RA, SLE, OA); novel concepts in pediatric rheumatology; and post-COVID telerheumatology sessions.

Read Article
eye%20exa.jpg (keep)

ACR and Three Societies Agree on HCQ Eye Safety

d MedPage Today

Four major medical societies issued a joint statement of principles on safe use of hydroxychloroquine from the perspective of ocular toxicity.

Read Article
gout podagra inflammed

MIRROR Study: Pegloticase With Methotrexate in Uncontrolled Gout

d Jack Cush, MD

Botson et al has reported that the combination of methotrexate (MTX) and IV pegloticase is safe and effective in patients with uncontrolled gout.

This exploratory, open-label clinical trial screened 17 patients and treated 14 patients (all men, 49.3 ± 8.7 years) with IV pegloticase with MTX (15 mg/week) and folic acid (1 mg/day) 4 weeks prior to and throughout pegloticase treatment.

Read Article
rwcsmtg.jpeg

RWCS Highlights - Day 3

d Rachel Tate, DO

Day 3 report from the 2021 RWCS meeting in Maui (and virtually) includes pearls from the PsA 2020 Year in Review; fact vs. fiction on evidence based medicine: diet and rheumatic diseases; hot topics in allergy/immunology; and pediatric rheumatology highlights.

Read Article
Common mucocutaneous findings in 35 kids w/ MIS-C & COVID: 1) conjunctival injection (21), palmoplantar erythema (18), lip hyperemia (17), periorbital erythema/edema (7), strawberry tongue (8), & malar erythema (6) https://t.co/mcSOXtXaEh

Links:

Dr. John Cush RheumNow ( View Tweet)

RWCS Highlights - Day 4 from Dr. Rachel Tate ( @uptotate) -Novel Therapies Year in Review (RA, SLE, OA) -Novel concepts in Pediatric Rheumatology -TeleRheumatology Update: Post-COVID, Pre-?? https://t.co/JoTV25suxD https://t.co/Id19zgRT37

Links:

Dr. John Cush RheumNow ( View Tweet)
ACR and Three Societies Agree on HCQ Eye Safety Four major medical societies issued a joint statement of principles on safe use of hydroxychloroquine from the perspective of ocular toxicity. https://t.co/3ALK3MpOen https://t.co/SzScNXgoqn

Links:

Dr. John Cush RheumNow ( View Tweet)
MIRROR Study: Pegloticase With Methotrexate in Uncontrolled Gout Botson et al has reported that the combination of methotrexate (MTX) and IV pegloticase is safe and effective in patients with uncontrolled gout. https://t.co/DRkIMOAhs4 https://t.co/2dft1QjC6E

Links:

Dr. John Cush RheumNow ( View Tweet)
30 #RA pts treated w/ tofacitinib x 12 mos w/ signif improvement in DAS28, CRP, & HAQ and attenuation of further bone loss, as measured by significantly increased osteocalcin, OPG, and vitamin D3, with decreased CTX levels correlating w/ DXA results https://t.co/RSXL38cJvs

Links:

Dr. John Cush RheumNow ( View Tweet)

Dr. Lindsey A. Criswell was sworn in this morning as the new director of NIAMS. https://t.co/4LxsX9Lh1W
NIAMS/NIH/DHHS NIH_NIAMS ( View Tweet)
🔥 Increased baseline prevalence and 40% higher risk of developing #Multimorbidity after #RA incidence/index vs general population @CrowsonCindy @JohnDavisIII #MayoClinicRheumatology ⁦@jrheum⁩ ⁦@NIAMSFunding⁩ ⁦@NIH⁩ https://t.co/8GolTowAGm

Links:

Elena MyasoedovaMD MyasoedovaElena ( View Tweet)

Consults in Cars--Is this the future of telehealth? https://t.co/INbKZ3xxty https://t.co/9Wj2eXy71l

Links:

Dr. John Cush RheumNow ( View Tweet)
Download Available--TNF Inhibitor -Cycle TNFi or Switch MOA? https://t.co/PgmTDYltpX

Links:

Dr. John Cush RheumNow ( View Tweet)

RWCS Highlights - Day 3 -Psoriatic Arthritis -Evidence Based Medicine: Diet and Rheumatic Diseases -Hot topics in Allergy/Immunology -Pediatric Rheumatology – past, present, and future https://t.co/CaKAyhxId3 https://t.co/5m882bcTOo

Links:

Dr. John Cush RheumNow ( View Tweet)
Prospective study of 162 early RA pts looked at Xrays (baseline & 5 yrs). RF & ESR predicted erosion & JSN progression; CCP predicted erosions; Smoking & high DAS28 > 5.1 predicted progression of erosions. Obesity negatively predicted JSN progression https://t.co/fue121hHVw

Links:

Dr. John Cush RheumNow ( View Tweet)

Study of Systemic Sclerosis patients from the EUSTAR database: shows of the 144 with anti-PM/Scl+ Abs, there was an increased risk of muscle involvement, ILD, calcinosis and dermatomyositis; muscle involvement had a more severe disease phenotype. https://t.co/ORA2y1BWgn

Links:

Dr. John Cush RheumNow ( View Tweet)

Join us at RheumNow Live next month in Texas or virtually! CME credits available. https://t.co/uwxOVh142F https://t.co/58BvLesevP

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Podcast: 2021 RWCS Review Drs. Jack Cush and Arthur Kavanaugh recap highlights from the 2021 Rheumatology Winter Clinical Symposium. https://t.co/iyYaO3NOBS

Links:

Dr. John Cush RheumNow ( View Tweet)

Video---Proposal of Novel Multimodal Outcome Instrument for Assessing SLE Activity--RWCS 2021 Poster Session by Dr. Barbara Jacobs, UC-San Diego https://t.co/3H4iNssyrZ

Links:

Dr. John Cush RheumNow ( View Tweet)

RWCS Highlights - Day 2 by Dr. Rachel Tate ( @uptotate) -What’s new in Spondyloarthritis -Osteoporosis and Beyond -Immunologic basis and clinical characteristics https://t.co/q4lI2BYhfz https://t.co/Q79CHaQrHf

Links:

Dr. John Cush RheumNow ( View Tweet)
×